Cargando…
Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
The incidence of prostate cancer (PCa) in men globally increases as the standard of living improves. Blood serum biomarker prostate‐specific antigen (PSA) detection is the gold standard assay that do not meet the requirements of early detection. Herein, a solution‐gated graphene transistor (SGGT) bi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896035/ https://www.ncbi.nlm.nih.gov/pubmed/36480308 http://dx.doi.org/10.1002/advs.202205886 |
_version_ | 1784881978807418880 |
---|---|
author | Deng, Minghua Ren, Zhanpeng Zhang, Huibin Li, Ziqin Xue, Chenglong Wang, Jianying Zhang, Dan Yang, Huan Wang, Xianbao Li, Jinhua |
author_facet | Deng, Minghua Ren, Zhanpeng Zhang, Huibin Li, Ziqin Xue, Chenglong Wang, Jianying Zhang, Dan Yang, Huan Wang, Xianbao Li, Jinhua |
author_sort | Deng, Minghua |
collection | PubMed |
description | The incidence of prostate cancer (PCa) in men globally increases as the standard of living improves. Blood serum biomarker prostate‐specific antigen (PSA) detection is the gold standard assay that do not meet the requirements of early detection. Herein, a solution‐gated graphene transistor (SGGT) biosensor for the ultrasensitive and rapid quantification detection of the early prostate cancer‐relevant biomarker, miRNA‐21 is reported. The designed single‐stranded DNA (ssDNA) probes immobilized on the Au gate can hybridize effectively with the miRNA‐21 molecules targets and induce the Dirac voltage shifts of SGGT transfer curves. The limit of detection (LOD) of the sensor can reach 10(−20) M without amplification and any chemical or biological labeling. The detection linear range is from 10(−20) to 10(−12) M. The sensor can realize real‐time detection of the miRNA‐21 molecules in less than 5 min and can well distinguish one‐mismatched miRNA‐21 molecule. The blood serum samples from the patients without RNA extraction and amplification are measured. The results demonstrated that the biosensor can well distinguish the cancer patients from the control group and has higher sensitivity (100%) than PSA detection (58.3%). Contrastingly, it can be found that the PSA level is not directly related to PCa. |
format | Online Article Text |
id | pubmed-9896035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98960352023-02-08 Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis Deng, Minghua Ren, Zhanpeng Zhang, Huibin Li, Ziqin Xue, Chenglong Wang, Jianying Zhang, Dan Yang, Huan Wang, Xianbao Li, Jinhua Adv Sci (Weinh) Research Articles The incidence of prostate cancer (PCa) in men globally increases as the standard of living improves. Blood serum biomarker prostate‐specific antigen (PSA) detection is the gold standard assay that do not meet the requirements of early detection. Herein, a solution‐gated graphene transistor (SGGT) biosensor for the ultrasensitive and rapid quantification detection of the early prostate cancer‐relevant biomarker, miRNA‐21 is reported. The designed single‐stranded DNA (ssDNA) probes immobilized on the Au gate can hybridize effectively with the miRNA‐21 molecules targets and induce the Dirac voltage shifts of SGGT transfer curves. The limit of detection (LOD) of the sensor can reach 10(−20) M without amplification and any chemical or biological labeling. The detection linear range is from 10(−20) to 10(−12) M. The sensor can realize real‐time detection of the miRNA‐21 molecules in less than 5 min and can well distinguish one‐mismatched miRNA‐21 molecule. The blood serum samples from the patients without RNA extraction and amplification are measured. The results demonstrated that the biosensor can well distinguish the cancer patients from the control group and has higher sensitivity (100%) than PSA detection (58.3%). Contrastingly, it can be found that the PSA level is not directly related to PCa. John Wiley and Sons Inc. 2022-12-08 /pmc/articles/PMC9896035/ /pubmed/36480308 http://dx.doi.org/10.1002/advs.202205886 Text en © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Deng, Minghua Ren, Zhanpeng Zhang, Huibin Li, Ziqin Xue, Chenglong Wang, Jianying Zhang, Dan Yang, Huan Wang, Xianbao Li, Jinhua Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis |
title | Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis |
title_full | Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis |
title_fullStr | Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis |
title_full_unstemmed | Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis |
title_short | Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis |
title_sort | unamplified and real‐time label‐free mirna‐21 detection using solution‐gated graphene transistors in prostate cancer diagnosis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896035/ https://www.ncbi.nlm.nih.gov/pubmed/36480308 http://dx.doi.org/10.1002/advs.202205886 |
work_keys_str_mv | AT dengminghua unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT renzhanpeng unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT zhanghuibin unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT liziqin unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT xuechenglong unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT wangjianying unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT zhangdan unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT yanghuan unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT wangxianbao unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis AT lijinhua unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis |